Embecta Corp has a consensus price target of $16.67 based on the ratings of 3 analysts. The high is $26 issued by BTIG on November 27, 2024. The low is $12 issued by Mizuho on July 16, 2025. The 3 most-recent analyst ratings were released by Mizuho on July 16, 2025, May 23, 2025, and April 10, 2025, respectively. With an average price target of $13.33 between Mizuho, there's an implied 36.75% upside for Embecta Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/16/2025 | 23.08% | Mizuho | $13 → $12 | Maintains | Neutral | |||
05/23/2025 | 33.33% | Mizuho | $15 → $13 | Maintains | Neutral | |||
04/10/2025 | 53.85% | Mizuho | → $15 | Initiates | → Neutral | |||
11/27/2024 | 166.67% | BTIG | → $26 | Upgrade | Neutral → Buy | |||
07/15/2024 | 23.08% | Morgan Stanley | $13 → $12 | Maintains | Underweight | |||
05/10/2024 | 33.33% | Morgan Stanley | $16 → $13 | Maintains | Underweight | |||
11/22/2023 | 64.1% | Morgan Stanley | $15 → $16 | Maintains | Underweight | |||
10/18/2023 | 53.85% | Morgan Stanley | $16 → $15 | Maintains | Underweight | |||
08/24/2023 | 64.1% | Morgan Stanley | $19 → $16 | Maintains | Underweight | |||
07/18/2023 | 94.87% | Morgan Stanley | $29 → $19 | Maintains | Underweight | |||
05/15/2023 | 197.44% | Morgan Stanley | $28 → $29 | Maintains | Underweight | |||
01/06/2023 | 187.18% | Morgan Stanley | → $28 | Downgrade | Equal-Weight → Underweight | |||
12/21/2022 | 217.95% | Morgan Stanley | $33 → $31 | Maintains | Equal-Weight | |||
10/11/2022 | 238.46% | Morgan Stanley | $36 → $33 | Maintains | Equal-Weight | |||
09/08/2022 | — | BTIG | — | Initiates | → Neutral | |||
08/16/2022 | 269.23% | Morgan Stanley | $33 → $36 | Maintains | Equal-Weight | |||
08/01/2022 | 238.46% | Morgan Stanley | → $33 | Initiates | → Equal-Weight |
The latest price target for Embecta (NASDAQ:EMBC) was reported by Mizuho on July 16, 2025. The analyst firm set a price target for $12.00 expecting EMBC to rise to within 12 months (a possible 23.08% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for Embecta (NASDAQ:EMBC) was provided by Mizuho, and Embecta maintained their neutral rating.
The last upgrade for Embecta Corp happened on November 27, 2024 when BTIG raised their price target to $26. BTIG previously had a neutral for Embecta Corp.
The last downgrade for Embecta Corp happened on January 6, 2023 when Morgan Stanley changed their price target from N/A to $28 for Embecta Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Embecta, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Embecta was filed on July 16, 2025 so you should expect the next rating to be made available sometime around July 16, 2026.
While ratings are subjective and will change, the latest Embecta (EMBC) rating was a maintained with a price target of $13.00 to $12.00. The current price Embecta (EMBC) is trading at is $9.75, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.